Lite Strategy, Inc. (LITS)

1.43 +0.25 (+21.19%) USD  |  NASDAQ  |  Sep 24, 16:00
1.52 +0.09 (+6.29%) Pre-Market: 08:59
More

Lite Strategy Gross Profit (Annual) : -0.368M for June 30, 2025

Gross Profit (Annual) Chart

View Gross Profit (Annual) for LITS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Gross Profit (Annual) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2025 -0.368M
June 30, 2024 64.91M
June 30, 2023 47.00M
June 30, 2022 39.46M
June 30, 2021 33.39M
June 30, 2020 26.24M
June 30, 2019 0.652M
June 30, 2018 -1.761M
June 30, 2017 18.25M
June 30, 2016 -0.058M
June 30, 2015 -0.064M
June 30, 2014 -0.05M
Date Value
June 30, 2013 -0.045M
June 30, 2012 -0.013M
June 30, 2011 -0.013M
June 30, 2010 0.00
June 30, 2009 0.00
June 30, 2008 0.00
June 30, 2007 0.00
June 30, 2006 0.00
June 30, 2005 0.00
June 30, 2004 0.00
June 30, 2003 0.00
June 30, 2002 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. 0.00
ACADIA Pharmaceuticals, Inc. 971.62M
Alnylam Pharmaceuticals, Inc. 3.032B
Anika Therapeutics, Inc. 63.81M
Savara, Inc. -0.245M